Skip to main content
. 2021 Nov 17;10:21649561211059074. doi: 10.1177/21649561211059074

Table 1.

Patient and cycle characteristics.

Group a
Characteristic Placebo (n=31) LA (n=31) P Value
Patient
 Age, y 33.4 (4.6) 31.5 (3.2) .06 b
 BMI 27.3 (5.9) 27.6 (6.8) .83 b
 White race 27 (87.1) 30 (96.8) .35 c
 Infertility period, y 1.4 (1.1) 1.2 (1.2) .45
 Previous IUI 16 (51.6) 15 (48.4) .79 d
 FSH, IU/L 6.9 (2.1) 7.1 (1.7) .76 b
  Missing, No. 9 7
 Estradiol, pg/mL 44.6 (30.7) 45.6 (37.1) .81 b
  Missing, No. 9 9
 AMH, ng/mL 4.2 (5.2) 3.7 (2.2) .67 b
  Missing, No 4 0
 Antral follicle count 21.4 (13.9) 25.9 (13.9) .25 b
  Missing, No. 4 5
HADS score
  Anxiety 5.5 (3.1) 6.5 (3.2) .22 b
  Depression 1.9 (3.1) 1.8 (2.3) .89 b
Cycle
 Protocols >.99 c
  Clomiphene citrate 20 (64.5) 19 (61.3)
  Letrozole 7 (22.6) 7 (22.6)
  Gonadotropin 2 (6.5) 3 (9.7)
  Natural cycle 2 (6.5) 2 (6.5)
 hCG trigger 22 (71.0) 20 (64.5) .59 d
 Partner present 15 (48.4) 16 (51.6) .80 d
 Follicular recruitment 2.7 (1.5) 3.0 (1.9) .46 b
  Missing, No. 7 10
 Endometrial echo complex, mm 7.1 (2.9) 6.8 (2.9) .82 b
  Missing, No. 7 10
 IUI procedure .68 c
  Easy 25 (80.7) 22 (71.0)
  Moderately easy 2 (6.5) 3 (9.7)
  Difficult 4 (12.9) 6 (19.3)
 Total motile sperm count, ×106 64.2 (58.5) 34.5 (30.1) .02 b
 Sperm motility, % 79.0 (15.5) 74.5 (15.9) .26 b
 Progesterone supplementation 5 (16.1) 4 (12.9) >.99 c

Abbreviations: AMH, anti-Müllerian hormone; BMI, body mass index; FSH, follicle-stimulation hormone; HADS, hospital anxiety and depression scale; hCG, human chorionic gonadotropin; IUI, intrauterine insemination; LA, lavender aromatherapy.

aData represent mean (SD) or number (percentage) unless otherwise specified.

bt test used for continuous variables.

cFisher exact test used for categorical variables as appropriate.

dχ2 used for categorical variables as appropriate.